Immunex/Wyeth Enbrel Launch Price Is $10,400 Per Year
Immunex is seeking a three-fold price premium for its rheumatoid arthritis therapy Enbrel (etanercept) over the most recent new entry into the class.
Immunex is seeking a three-fold price premium for its rheumatoid arthritis therapy Enbrel (etanercept) over the most recent new entry into the class.